The optimal dose of apixaban therapy to prevent asecondary venous thromboembolism (VTE) event remains unconfirmed. Click to show full abstract
The optimal dose of apixaban therapy to prevent asecondary venous thromboembolism (VTE) event remains unconfirmed.
               
Click one of the above tabs to view related content.